Microsatellite instability cancer represents a unique group of tumors marked by errors in the body’s DNA repair system, leading to unusual changes in short, repeated sections of genetic code scattered throughout our genes.

Understanding Microsatellite Instability

To understand microsatellite instability cancer, we first need to look at what microsatellites are. Microsatellites, also called short tandem repeats, are small stretches of DNA made up of one to six building blocks called nucleotides that repeat over and over again. These repeating sequences are found throughout the entire human genome and make up approximately three percent of all our genetic material. They are scattered in various regions, including areas near genes that contain instructions for making proteins, as well as in sections that don’t code for proteins at all.^[3]

These microsatellite regions are naturally prone to errors when cells divide and copy their DNA. During this copying process, the DNA strands can slip or become misaligned, causing one or more of the repeating units to be accidentally deleted or inserted. Think of it like a typist who accidentally skips or repeats a word while copying a document. In healthy cells, a sophisticated proofreading system called mismatch repair (MMR) catches and fixes these mistakes. This repair system constantly scans the newly copied DNA, identifies where bases have been matched incorrectly, and corrects the errors before they become permanent.^[7]

Microsatellite instability (MSI) occurs when this mismatch repair system is not working properly. When the MMR genes are defective or absent in tumor cells, the DNA copying errors cannot be fixed. Each time the cell divides, these mistakes accumulate, and the microsatellite regions change in length. This creates instability in the genetic code. The result is a cancer cell with numerous mutations scattered throughout its DNA, particularly in these repetitive microsatellite regions.^[5]

Doctors classify microsatellite instability into different types based on how frequently these changes occur. Microsatellite instability-high (MSI-H) describes tumors where many microsatellite markers show changes. Microsatellite instability-low (MSI-L) means only a few markers are altered. Microsatellite stable (MSS) tumors show no significant changes in these regions. For practical purposes in treatment decisions, doctors often group MSI-L and MSS tumors together, as they behave similarly, while MSI-H tumors represent a distinct category with different characteristics and treatment responses.^[7]

Epidemiology

Microsatellite instability appears in various types of cancer, though its frequency differs considerably depending on the cancer type. In colorectal cancer, approximately fifteen to twenty percent of cases display high microsatellite instability. This makes it one of the more common molecular alterations in this disease. The presence of MSI-H is found most often in colorectal cancer, but it also appears in other types of gastrointestinal cancers and endometrial cancer.^[3]

Looking at specific numbers, about one in three endometrial cancers are MSI-H. Among colorectal, stomach, and ovarian cancers, approximately one in seven cases show this characteristic. Beyond these common sites, MSI can also be detected in cancers of the breast, prostate, bladder, thyroid, and small bowel, though less frequently.^[14]

About fifteen percent of colorectal carcinomas demonstrate high MSI. This finding has important implications because it affects how the disease behaves and how it should be treated. High MSI is particularly significant in colorectal cancer because it serves as a hallmark of a hereditary condition called Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer. A high proportion of colon cancers arising in patients with Lynch syndrome have high MSI, though a smaller percentage of colon cancers not associated with this inherited syndrome also show MSI-H characteristics.^[8]

Causes

The fundamental cause of microsatellite instability cancer lies in problems with the DNA mismatch repair system. This repair system depends on several genes working together properly. When one or more of these MMR genes stops functioning correctly, the cell loses its ability to fix copying errors that naturally occur during DNA replication. The most common markers associated with mismatch repair are MLH1, MSH2, MSH6, and PMS2. These genes encode proteins that work together to identify and repair mistakes in the genetic code.^[8]

There are two main ways that the mismatch repair system can fail, leading to different types of MSI cancer. In most cases, the change happens during a person’s lifetime within cancer cells themselves, with no clear external cause known. These are called sporadic cases. In sporadic colorectal cancer with MSI-H, the problem usually stems from a process called methylation of the hMLH1 promoter. Methylation is an epigenetic change, meaning it affects how genes are expressed without actually changing the DNA sequence itself. When the promoter region of the hMLH1 gene becomes heavily methylated, the gene is silenced, and the cell can no longer produce the MLH1 protein needed for DNA repair.^[7]

The second way mismatch repair can fail is through inherited genetic mutations. Lynch syndrome is an autosomal dominant hereditary condition caused by mutations in MMR genes that are passed down from parent to child. People with Lynch syndrome inherit one faulty copy of an MMR gene, which significantly increases their risk of developing cancer. When the second, healthy copy of the gene becomes damaged or lost in a cell, the mismatch repair system fails completely, and that cell becomes prone to accumulating mutations. Lynch syndrome not only increases the risk of colorectal cancer but can also lead to tumors in other parts of the body, including the endometrium, ovaries, stomach, small intestine, and other organs.^[7]

Risk Factors

The primary risk factor for developing microsatellite instability cancer is having Lynch syndrome. This inherited condition puts individuals at significantly higher risk for MSI-H tumors. People with Lynch syndrome have a mutation in one of the mismatch repair genes that they inherited from a parent. This hereditary factor means that cancer can develop at younger ages compared to sporadic cases, and affected individuals may develop multiple primary cancers during their lifetime.^[8]

Family history plays a crucial role in identifying those at risk. If several family members across multiple generations have had colorectal cancer, endometrial cancer, ovarian cancer, or certain other cancers, particularly if diagnosed before age fifty, this pattern suggests possible Lynch syndrome. People with this family history should discuss genetic counseling with their healthcare provider to assess whether genetic testing would be appropriate.^[8]

For sporadic MSI-H cancers, which make up the majority of MSI cases, the risk factors are less clearly defined. These cancers develop without a clear inherited genetic predisposition, and the methylation of the MLH1 gene that causes them occurs for reasons that are not yet fully understood. The general risk factors for colorectal cancer and other cancers where MSI can occur, such as age, diet, lifestyle factors, and environmental exposures, may play a role, but the specific triggers for developing MSI-H versus other types of cancer remain an active area of research.^[7]

Symptoms

Microsatellite instability itself does not cause specific symptoms that would distinguish it from other types of cancer. The symptoms a person experiences depend entirely on the type of cancer they have and where it is located in the body. For example, someone with MSI-H colorectal cancer will experience symptoms related to colon or rectal tumors, not symptoms unique to the MSI-H characteristic of their tumor.^[16]

In MSI-H colorectal cancer, which is the most studied form, symptoms may include changes in bowel habits such as diarrhea, constipation, or a persistent feeling of needing to have a bowel movement even after just going to the bathroom. Blood in the stool is another common sign, which may appear as bright red blood from the rectum or make the stool look dark brown or black. Abdominal pain, cramping, and bloating can also occur. Some people may not notice obvious symptoms but may develop anemia from chronic, slow bleeding in the colon, leading to fatigue and weakness.^[16]

For MSI-H endometrial cancer, symptoms typically include abnormal vaginal bleeding, particularly bleeding after menopause or bleeding between periods in women who haven’t yet reached menopause. Pelvic pain or discomfort may also occur. In gastric or stomach cancers with MSI-H, symptoms might include abdominal pain, unintentional weight loss, nausea, difficulty swallowing, or feeling full after eating only small amounts of food.^[16]

It’s important to understand that many of these symptoms can be caused by conditions other than cancer. However, persistent symptoms, especially bleeding from the rectum, blood in the stool, or severe abdominal pain, should prompt immediate medical attention. Changes in bowel habits or persistent bloating that last more than two weeks also warrant a discussion with a doctor. Early detection significantly improves outcomes, regardless of the molecular characteristics of the cancer.^[16]

Prevention

For sporadic MSI-H cancers, where the cause is not clearly understood, prevention strategies are similar to those recommended for preventing cancer in general. These include maintaining a healthy diet rich in fruits, vegetables, and whole grains while limiting processed meats and red meat. Regular physical activity, maintaining a healthy body weight, avoiding tobacco, and limiting alcohol consumption all contribute to reducing overall cancer risk.^[16]

For individuals with Lynch syndrome or a strong family history suggesting possible hereditary cancer risk, prevention takes on additional dimensions. Genetic counseling and testing can identify whether someone carries a mutation in an MMR gene. If Lynch syndrome is confirmed, more intensive screening programs can be implemented. This typically includes colonoscopy starting at a younger age and performed more frequently than in the general population. For women with Lynch syndrome, screening for endometrial and ovarian cancer may also be recommended, and some women choose to have preventive surgery to remove the uterus and ovaries after completing their families.^[8]

Regular cancer screening is crucial for early detection. For colorectal cancer, screening guidelines recommend that most people begin regular screening at age forty-five. However, people with Lynch syndrome or a significant family history should start screening earlier and undergo more frequent testing. Various screening methods are available, including colonoscopy, which can both detect and remove precancerous polyps, potentially preventing cancer from developing at all. Other screening options include stool-based tests that can detect hidden blood or abnormal DNA.^[16]

Pathophysiology

The pathophysiology of microsatellite instability cancer revolves around the accumulation of genetic mutations due to a faulty DNA repair system. When cells divide, they must copy their entire genome, consisting of billions of DNA base pairs. During this massive copying operation, errors inevitably occur. The DNA is made up of four bases—adenine, thymine, cytosine, and guanine, abbreviated as A, T, C, and G. These bases pair up in specific ways: A with T, and C with G. During DNA replication, these bases must be matched correctly on the new strand being created.^[5]

In microsatellite regions, where the same short sequence repeats many times, the DNA strands can easily slip during copying. For example, in a region with many consecutive As and Ts, the copying machinery might skip one or add an extra one. The mismatch repair system normally catches these errors by scanning the newly synthesized DNA strand. When it finds a mismatch—such as an A paired with a C instead of a T—it cuts out the incorrect base and replaces it with the correct one.^[5]

In MSI-H cancer cells, this repair system is broken. Without functional MMR proteins, mistakes in microsatellite regions persist and accumulate with each cell division. Over time, these microsatellite sequences become longer or shorter than they should be, hence the term “instability.” This instability extends beyond just the microsatellites themselves. The overall failure of the mismatch repair system means that mutations accumulate throughout the genome, not just in microsatellite regions.^[5]

Recent research has revealed more details about why MSI-H cancer cells are so vulnerable to certain treatments. Scientists have discovered that in MSI-H cancer cells, long stretches of repeated T and A bases form unusual DNA structures. An enzyme called WRN normally unwinds these unusual structures. But when WRN is removed from MSI-H cancer cells, these unusual DNA structures eventually cause the DNA to shatter, killing the cells. Importantly, normal cells and non-MSI cancer cells don’t depend on WRN in the same way, which is why targeting WRN could potentially be a selective treatment for MSI-H cancers.^[14]

The high number of mutations in MSI-H tumors has an important consequence for how the immune system sees these cancer cells. Many of the mutations create abnormal proteins that have never existed in the body before, called neoantigens. These neoantigens are recognized by the immune system as foreign, similar to how the immune system recognizes viruses or bacteria. This recognition means that MSI-H tumors are often heavily infiltrated with immune cells trying to attack the cancer. However, many MSI-H tumors have learned to evade this immune attack by expressing proteins that put the brakes on immune responses, such as PD-L1. This is why treatments that release these brakes, called checkpoint inhibitors, can be particularly effective in MSI-H cancers.^[9]